As with other drugs, Remicade (infliximab) can cause side effects, such as infusion reactions. If you are not able to tolerate side effects of Remicade, talk with your doctor or pharmacist.

As an urban university, Boston University can sometimes feel devoid of green space. A new 92-by-45-foot garden located east ...

Just yesterday, Singapore-based Venturi Partners launched its second fund with a corpus of $225 Mn to back consumer brands in India and Southeast Asia. Earlier this month, US-based Bessemer ...

Venturi Partners, a growth-stage consumer-focused investor in India and Southeast Asia, has announced the launch of its second fund, targeting $225 million, with a cap of $250 million. The second fund ...

Venturi Partners, a growth-stage consumer-focused investor in India and Southeast Asia, has launched its second fund, targetting a corpus of $225-250 million. The Singapore-based firm has backed a ...

Venturi Partners, a growth-stage consumer-focused investment firm, has announced the launch of its second fund with a target corpus of $225 million, with a hard cap of $250 million, to invest in ...

Ashok P Hinduja, Chairman of IndusInd International Holdings Ltd (IIHL), stated on March 18 that it is an ideal time for the company to increase its stake in IndusInd Bank. Hinduja expressed his ...

The firm plans to invest $15 Mn to $40 Mn each in 10 startups from the second fund. Venturi Partners’ first fund, which had a corpus of $175 Mn, invested in seven companies across sectors such ...

Venturi Partners, a Singapore-based investment firm that backs consumer-focused startups in India and Southeast Asia, has floated its second flagship fund targeting a bigger corpus than its maiden ...